Calcium Channel Blocker Versus Renin–Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score‐Matched Cohort Study

Ähnliche Einträge

• Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population
  von: Minji Jung, et al.
  Veröffentlicht: (2024)
• Screening and Diagnosis of Primary Aldosteronism in Patients Using Renin‐Angiotensin System Inhibitors
  von: Qian Wang, et al.
  Veröffentlicht: (2026)
• Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
  von: Kazuomi Kario, et al.
  Veröffentlicht: (2024)
• Letter to the Editor: “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes”
  von: Sabika Ayesha, et al.
  Veröffentlicht: (2025)
• Kaempferol Ameliorates Renal Remodelling by Inhibiting the Renin‐Angiotensin System Cascade in Hypertensive Rats
  von: Putcharawipa Maneesai, et al.
  Veröffentlicht: (2024)